Lumenis Offers Advanced Surgical Solutions Alongside Comprehensive CO2 Laser Educational Sessions at COSM 2016
May 18 2016 - 9:46AM
Lumenis Ltd., the world’s largest energy-based medical device
company for surgical, aesthetic and ophthalmic applications,
announced it will be collaborating with leading educational
institutes, residents and fellows to provide training sessions for
the state-of-the-art UltraPulse DUO and AcuPulse DUO surgical
solutions, at the annual Combined Otolaryngology Spring Meetings
(COSM), being held in Chicago from May 18-22, 2016.
Photos accompanying this announcement are available
at
http://www.globenewswire.com/NewsRoom/AttachmentNg/fac15f52-eefc-4c2c-8890-9901c2a5b460
http://www.globenewswire.com/NewsRoom/AttachmentNg/dc9b2b4e-b273-4796-ab66-9b4fcc86153a
With its high microsurgical precision, the UltraPulse
CO2 laser technology has been considered the industry’s gold
standard solution for minimally invasive delicate procedures for
more than a decade. The new UltraPulse DUO features the
ultra-precise Digital AcuBlade scanning micromanipulator capability
and superior fiber energy delivery all within the same platform,
helping physicians achieve the master’s touch and improve patient
care.
“The UltraPulse DUO features unique energy delivery
capabilities, providing maximum control over desired clinical
outcomes. The combination of the two modalities allows ENT surgeons
to expand and operate beyond their line-of-sight and address
clinical challenges which cannot be otherwise addressed by a
platform with a single mode of energy delivery,” said Paul
Castellanos, M.D., Associate Professor of Surgery at the University
of Alabama at Birmingham. “With the system’s precision and clear
margin visibility, I am better able to treat patients by preserving
healthy, delicate tissue and provide patients with a safer and more
efficient surgery experience.”
As an addition to the Lumenis DUO product family, the UltraPulse
DUO joins the AcuPulse DUO, the first integrated CO2 laser
system to deliver a combination of laser modalities. Providing a
seamless adjustment between the two therapeutic modalities, both
systems are accompanied by a wide range of surgical tools, along
with cost effective fibers that feature renewable tips,
aiming beam and high energy transmission. The versatile Lumenis DUO
product line is designed for smart tissue management and for
optimal treatment of hard-to-reach delicate anatomy.
COSM conference attendees are invited to join UltraPulse DUO and
AcuPulse DUO training sessions to obtain first-hand experience with
the latest head and neck surgical innovations. As part of its
ongoing commitment to focus on better patient care, Lumenis will
also be hosting the “Leave No Disease Behind” challenge, in which
residents and fellows have the opportunity to experience the
precision of Lumenis CO2 laser surgical solutions. Lumenis
will sponsor the winner of the challenge to attend and participate
in Memorial Sloan Kettering’s Hands–on Transoral Laser Microsurgery
for Head and Neck Cancer Course.
“For 50 years, Lumenis has been dedicated to developing advanced
products and delivering innovative solutions. Our comprehensive
approach includes not only providing the best-in-class products,
but also partnering with leading educational institutions to
positively impact the quality of patient care,” said Tzipi
Ozer-Armon, CEO of Lumenis. “Thousands of patients all over the
world have experienced improved care from surgeons who enhance
their surgical capabilities with Lumenis’ innovative CO2 laser
technology solutions, and we look forward to continuing our legacy
with our commitment to educate the next generation of healthcare
professionals.”
To learn more about Lumenis and its portfolio of ENT solutions,
please visit the COSM booth #410.
About Lumenis Lumenis is a global leader in the
field of minimally-invasive clinical solutions for the Surgical,
Ophthalmology and Aesthetic markets, and is a world-renowned expert
in developing and commercializing innovative energy-based
technologies, including Laser, Intense Pulsed Light (IPL) and
Radio-Frequency (RF). For nearly 50 years, Lumenis' ground-breaking
products have redefined medical treatments and have set numerous
technological and clinical gold-standards. Lumenis has
successfully created solutions for previously untreatable
conditions, as well as designed advanced technologies that have
revolutionized existing treatment methods. For more information
visit: www.lumenis.com
For further information:
Glenn Silver
Lazar Partners Ltd.
(646) 871-8495
LUMENIS LTD (NASDAQ:LMNS)
Historical Stock Chart
From May 2024 to Jun 2024
LUMENIS LTD (NASDAQ:LMNS)
Historical Stock Chart
From Jun 2023 to Jun 2024